Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00038194
Status:
COMPLETED
Last Update Posted:
2018-10-31
First Post:
2002-05-29
Brief Title:
Phase I Trial of Fixed Dose STI571 Imatinib Mesylate With Escalating Doses of Docetaxel in Patients With Metastatic Androgen-Independent Prostate Cancer
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center